Variant report
Variant | rs12506365 |
---|---|
Chromosome Location | chr4:166281785-166281786 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:166277600-166285400 | Weak transcription | HepG2 | liver |
2 | chr4:166278200-166282800 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr4:166279200-166281800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:166280200-166284800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
5 | chr4:166280400-166281800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
6 | chr4:166280400-166282000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr4:166280400-166282400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr4:166281000-166282000 | Enhancers | Adipose Nuclei | Adipose |
9 | chr4:166281000-166282000 | Enhancers | NHDF-Ad | bronchial |
10 | chr4:166281000-166282600 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr4:166281200-166282000 | Bivalent Enhancer | Osteobl | bone |
12 | chr4:166281600-166282000 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr4:166281600-166285400 | Weak transcription | HMEC | breast |
14 | chr4:166281600-166285800 | Weak transcription | Hela-S3 | cervix |